Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Lustgarten
Matching Adjusted Indirect Comparison (MAIC) Analysis for Ponatinib vs Bosutinib in Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Alternative Weighting Approaches for Matching Adjusted Indirect Comparisons (Maic)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm239 - Does Matching Adjusted Indirect Comparison (Maic) Work? Results From a Simulation Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Role of Bosutinib in the Treatment of Chronic Myeloid Leukemia
Future Oncology
Medicine
Cancer Research
Oncology
PSY12 the Cost of Treating Chronic Myeloid Leukemia (CML) in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Efficacy and Tolerability of Front-Line Treatments for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: An Update Network Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Management of Chronic Myeloid Leukemia in Advanced Phase
Frontiers in Oncology
Cancer Research
Oncology
Cost-Effectiveness of Ponatinib in the Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bosutinib in the Management of Chronic Myelogenous Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
